Objective:This randomized clinical trial evaluated the efficacy and safety of a blue‐covarine whitening toothpaste on tooth bleaching.
Subjects and methods:Seventy‐five subjects with shade mean C1 or darker were randomized into three groups (n = 25): CT‐conventional toothpaste, WT‐whitening toothpaste, and CP10‐10% carbamide peroxide. Subjects from CT and WT brushed their teeth twice/day for 2 weeks. CP10 used bleaching gel for 4 hours/night for 2 weeks. Tooth shade and CIELab parameters were measured at baseline, after the first application, 2‐ and 4‐week. ΔE*ab and ΔE00 were calculated. Subjects' perception about tooth color appearance, tooth sensitivity (TS), and gingival irritation (GI) were also assessed.
Results:At all evaluation periods, it was not observed differences between WT and CT considering tooth shade (P > 0.7) or CIELab parameters (P > 0.3). At 2‐ and 4‐week, ΔE*ab and ΔE00 were higher for CP10 than WT or CT (P = 0.001). WT and CT reported major dissatisfaction with tooth color appearance than CP10 (P = 0.001). At 1‐ and 2‐week, WT experienced GI and TS similar to CT, both lower than CP10 (P < 0.01).
Conclusion:There were no significant differences in the whitening efficacy between whitening and conventional toothpastes. Neither of the dentifrices was as effective as at‐home bleaching.
Clinical significance:The silica‐based toothpaste containing blue covarine evaluated in this study did not give significant tooth whitening benefits over 2 weeks of use.